Genetics of hypertension

PURPOSE OF REVIEW: Hypertension genetics is transitioning from discovery into clinical applications: there are numerous genome-wide association studies (GWAS) of blood pressure (BP) and more recently resistant hypertension, polygenic risk scores are available, and there is regulatory approval of a novel class of antihypertensive treatment. This review highlights recent discoveries and clinical implications. RECENT FINDINGS: A GWAS of greater than 1 million individuals identified 2103 independent BP signals, explaining more than 60% of common-variant heritability; many candidate genes are expressed in kidney tubular epithelia and adrenal zona glomerulosa. A GWAS (>23 000 cases) of resistant hypertension identified 24 loci with candidate genes mapping to the aldosterone-potassium axis, providing genetics support for selective aldosterone synthase inhibitors and overlap with BP loci. Clinical trials using aldosterone synthase inhibitors, and angiotensinogen-silencing RNA therapies are in Phase 2-3 trials; aprocitentan received regulatory approval for resistant hypertension in 2024. SUMMARY: The genetic architecture of hypertension spans Mendelian disease genes to thousands of common variants, with kidney tubular biology and the aldosterone axis as central biological themes. Multigene panels, primary aldosteronism screening, and mineralocorticoid axis evaluation before accepting apparent resistance are ready for clinical implementation. Polygenic risk scores show promise for trial enrichment and pharmacogenomic stratification, but are not yet ready for individual clinical decisions.

Authors

Institutions

Publication Details

Journal
Current Opinion in Nephrology & Hypertension
Published
2026-11-19
DOI
https://doi.org/10.1097/mnh.0000000000001245
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genetics of hypertension

Patricia B. Munroe, Marianna Danielli
1 links
Current Opinion in Nephrology & Hypertension
Blood Pressure and Hypertension Studies
article

Genetics of hypertension

Patricia B. Munroe, Marianna Danielli
article en

Abstract

PURPOSE OF REVIEW: Hypertension genetics is transitioning from discovery into clinical applications: there are numerous genome-wide association studies (GWAS) of blood pressure (BP) and more recently resistant hypertension, polygenic risk scores are available, and there is regulatory approval of a novel class of antihypertensive treatment. This review highlights recent discoveries and clinical implications. RECENT FINDINGS: A GWAS of greater than 1 million individuals identified 2103 independent BP signals, explaining more than 60% of common-variant heritability; many candidate genes are expressed in kidney tubular epithelia and adrenal zona glomerulosa. A GWAS (>23 000 cases) of resistant hypertension identified 24 loci with candidate genes mapping to the aldosterone-potassium axis, providing genetics support for selective aldosterone synthase inhibitors and overlap with BP loci. Clinical trials using aldosterone synthase inhibitors, and angiotensinogen-silencing RNA therapies are in Phase 2-3 trials; aprocitentan received regulatory approval for resistant hypertension in 2024. SUMMARY: The genetic architecture of hypertension spans Mendelian disease genes to thousands of common variants, with kidney tubular biology and the aldosterone axis as central biological themes. Multigene panels, primary aldosteronism screening, and mineralocorticoid axis evaluation before accepting apparent resistance are ready for clinical implementation. Polygenic risk scores show promise for trial enrichment and pharmacogenomic stratification, but are not yet ready for individual clinical decisions.

Current Opinion in Nephrology & Hypertension
Queen Mary University of London (GB), Barts Health NHS Trust (GB), William Harvey Research Institute (GB)
Good health and well-being
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon